Zusammenfassung
Das Prostatakarzinom (PCA) ist das häufigste Malignom des Mannes und zeigt eine steigende Inzidenz. Allein in Deutschland sterben ca. 11.000 Männer/Jahr. Erfreulicherweise sinkt die Mortalität bei steigender Inzidenz als Zeichen einer Verbesserung der diagnostischen Methoden. Viele Innovationen im Bereich der Bildgebung des PCA können hilfreich bei der frühzeitigen Erkennung eines PCA sein. Die kontrastmittelunterstützte Sonographie, computerunterstützte Sonographie, die Elastographie und das multiparamterische Magnetresonanztomogramm (MRT) sind vielversprechende Methoden, welche zu einer Steigerung der PCA-Detektionsrate führen können. Die Wertigkeit dieser neuen innovativen Techniken bezüglich der Detektion eines PCA ist nicht abschließend geklärt und soll anhand aktueller Daten dargestellt werden.
Abstract
Prostate cancer (PCA) is the most common malignancy in men with an increasing incidence and is responsible for about 11,000 deaths per year in Germany. Fortunately, the mortality of PCA has decreased in recent years despite the rising incidence reflecting improvements in diagnostic methods. Many new innovations in imaging techniques for PCA are available and may be helpful in early detection of PCA. Contrast-enhanced sonography, computer-assisted sonography, elastography and multiparametric magnetic resonance imaging (MRI) seem to be the most promising methods to increase the detection rate of PCA during diagnostic work-up. The value of these new innovative techniques concerning improvement in PCA detection is reviewed.
Literatur
Horwich A, Parker C, Bangma C, Kataja V (2010) ESMO Guidelines Working Group. Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 21(Suppl 5):129–133
Hegele A, Skrobek L, Schrader AJ (2012) Update uro-oncology: Scientific meetings 2011. Aktuelle Urol 43:1–7
Cooner WH, Mosley BR, Rutherford CL et al (1990) Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen. J Urol 143:1146–1154
Loch AC, Bannowsky A, Baeurle L et al (2007) Technical and anatomical essentials for transrectal ultrasound of the prostate. World J Urol 25:361–366
Flanigan RC, Catalona WJ, Richie JP et al (1994) Accuracy of digital rectal examination and transrectal ultrasonography in localizing prostate cancer. J Urol 152:1506–1509
Noguchi M, Stamey TA, McNeal JE, Yemoto CM (2001) Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer. J Urol 166:104–109
Sadeghi-Nejad H, Simmons M, Dakwar G, Dogra V (2006) Controversies in transrectal ultrasonography and prostate biopsy. Ultrasound Q 22:169–175
Scherr DS, Eastham J, Ohori M, Scardino PT (2002) Prostate biopsy techniques and indications: when, where, and how? Semin Urol Oncol 20:18–31
Djavan B, Margreiter M (2007) Biopsy standards for detection of prostate cancer. World J Urol 25:11–17
AWMF (2011) Interdisziplinäre Leitlinie der Qualität S3 zur Früerkennung, Diagnose und Therapie der verschiedenen Stadien des Prostatakarzinoms, Vers. 2.0–1. Aktualisierung 2011, Empfehlung 3.11. AWMF, Düsseldorf
Simon J, Kuefer R, Bartsch G Jr et al (2008) Intensifying the saturation biopsy technique for detecting prostate cancer after previous negative biopsies: a step in the wrong direction. BJU Int 102:459–462
Stewart CS, Leibovich BC, Weaver AL, Lieber MM (2001) Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. J Urol 166:86–91
Borboroglu PG, Comer SW, Riffenburgh RH, Amling CL (2000) Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies. J Urol 163:158–162
Zaytoun OM, Jones JS (2011) Prostate cancer detection after a negative prostate biopsy: lessons learnt in the Cleveland Clinic experience. Int J Urol 18:557–568
Heijmink SW, Fütterer JJ, Strum SS et al (2011) State-of-the-art uroradiologic imaging in the diagnosis of prostate cancer. Acta Oncol 50(Suppl 1):25–38
Dinter DJ, Weidner AM, Wenz F et al (2010) Imaging diagnostics of the prostate. Urologe A 49:963–975
Loch T (2004) Computerized supported transrectal ultrasound (C-TRUS) in the diagnosis of prostate cancer. Urologe A 43:1377–1384
Loch T (2007) Computerized transrectal ultrasound (C-TRUS) of the prostate: detection of cancer in patients with multiple negative systematic random biopsies. World J Urol 25:375–380
Pelzer A, Bektic J, Berger AP et al (2005) Prostate cancer detection in men with prostate specific antigen 4 to 10 ng/ml using a combined approach of contrast enhanced color Doppler targeted and systematic biopsy. J Urol 173(6):1926–1929
Aigner F, Pallwein L, Mitterberger M et al (2009) Contrast-enhanced ultrasonography using cadence-contrast pulse sequencing technology for targeted biopsy of the prostate. BJU Int 103:458–463
Mitterberger M, Horninger W, Aigner F et al (2010) Contrast-enhanced colour Doppler-targeted vs a 10-core systematic repeat biopsy strategy in patients with previous high-grade prostatic intraepithelial neoplasia. BJU Int 105:1660–1662
Wink M, Frauscher F, Cosgrove D et al (2008) Contrast-enhanced ultrasound and prostate cancer; a multicentre European research coordination project. Eur Urol 54:982–992
Mitterberger M, Horninger W, Pelzer A et al (2007) A prospective randomized trial comparing contrastenhanced targeted versus systematic ultrasound guided biopsies: impact on prostate cancer detection. Prostate 67:1537–1542
Taymoorian K, Thomas A, Slowinski T et al (2007) Transrectal broadband-Doppler sonography with intravenous contrast medium administration for prostate imaging and biopsy in men with an elevated PSA value and previous negative biopsies. Anticancer Res 27:4315–4320
AWMF (2011) Interdisziplinäre Leitlinie der Qualität S3 zur Früerkennung, Diagnose und Therapie der verschiedenen Stadien des Prostatakarzinoms, Vers. 2.0–1. Aktualisierung 2011, Empfehlungen 4.3–4.8. AWMF, Düsseldorf
Loch T, Leuschner I, Genberg C et al (2000) Improvement of transrectal ultrasound. Artificial neural network analysis (ANNA) in detection and staging of prostatic carcinoma. Urologe A 39:341–347
Grabski B, Baeurle L, Loch A et al (2011) Computerized transrectal ultrasound of the prostate in a multicenter setup (C-TRUS-MS): detection of cancer after multiple negative systematic random and in primary biopsies. World J Urol 29:573–579
Braeckman J, Autier P, Garbar C et al (2008) Computer-aided ultrasonography (HistoScanning): a novel technology for locating and characterizing prostate cancer. BJU Int 101:293–298
Braeckman J, Autier P, Soviany C et al (2008) The accuracy of transrectal ultrasonography supplemented with computer-aided ultrasonography for detecting small prostate cancers. BJU Int 102:1560–1565
Kamoi K, Okihara K, Ochiai A et al (2008) The utility of transrectal real-time elastography in the diagnosis of prostate cancer. Ultrasound Med Biol 34:1025–1032
Miyagawa T, Tsutsumi M, Matsumura T et al (2009) Real-time elastography for the diagnosis of prostate cancer: evaluation of elastographic moving images. Jpn J Clin Oncol 39:394–398
Tsutsumi M, Miyagawa T, Matsumura T et al (2007) The impact of real-time tissue elasticity imaging (elastography) on the detection of prostate cancer: clinicopathological analysis. Int J Clin Oncol 12:250–255
Eggert T, Khaled W, Wenske S et al (2008) Impact of elastography in clinical diagnosis of prostate cancer. A comparison of cancer detection between B-mode sonography and elastography-guided 10-core biopsies. Urologe A 47:1212–1217
Brock M, Bodman C von, Sommerer F et al (2011) Comparison of real-time elastography with grey-scale ultrasonography for detection of organ-confined prostate cancer and extra capsular extension: a prospective analysis using whole mount sections after radical prostatectomy. BJU Int 108(8 Pt 2):217–222, doi:10.1111/j.1464-410X.2011.10209.x
Walz J, Marcy M, Maubon T et al (2011) Real time elastography in the diagnosis of prostate cancer: Comparison of preoperative imaging and histology after radical prostatectomy. Prog Urol 21:925–931
Salomon G, Köllerman J, Thederan I et al (2008) Evaluation of prostate cancer detection with ultrasound real-time elastography: a comparison with step section pathological analysis after radical prostatectomy. Eur Urol 54:1354–1362
Pallwein L, Mitterberger M, Struve P et al (2007) Real-time elastography for detecting prostate cancer: preliminary experience. BJU Int 100:42–46
Seitz M, Shukla-Dave A, Bjartell A et al (2009) Functional magnetic resonance imaging in prostate cancer. Eur Urol 55:801–814
Turkbey B, Mani H, Shah V et al (2011) Multiparametric 3 T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds. J Urol 186:1818–1824
Hegele A, Heverhagen J, Blazek et al (o J) Multiparametric MRT in prostate cancer – correlation with histopathological results after radical prostatectomy. (Unpublished data)
Oto A, Yang C, Kayhan A et al (2011) Diffusion-Weighted and dynamic contrast-enhanced mri of prostate cancer: correlation of quantitative mr parameters with gleason score and tumor angiogenesis. AJR Am J Roentgenol 197:1382–1390
Tanimoto A, Nakashima J, Kohno H et al (2007) Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging. J Magn Reson Imaging 25:146–152
Chen M, Dang HD, Wang JY et al (2008) Prostate cancer detection: comparison of T2-weighted imaging, diffusion-weighted imaging, proton magnetic resonance spectroscopic imaging, and the three techniques combined. Acta Radiol 49:602–610
Reinsberg SA, Payne GS, Riches SF et al (2007) Combined use of diffusion-weighted MRI and 1 H MR spectroscopy to increase accuracy in prostate cancer detection. AJR Am J Roentgenol 188:91–98
Yoshida S, Kawakami S, Ishii C et al (2011) Diagnostic performance and optimal sequence of MRI in detecting prostate cancer. J Urol 185 (Suppl):338–339
Lawrentschuk N, Fleshner N (2009) The role of magnetic resonance imaging in targeting prostate cancer in patients with previous negative biopsies and elevated prostate-specific antigen levels. BJU Int 103:730–733
Sciarra A, Panebianco V, Ciccariello M et al (2010) Value of magnetic resonance spectroscopy imaging and dynamic contrast-enhanced imaging for detecting prostate cancer foci in men with prior negative biopsy. Clin Cancer Res 16:1875–1883
Cheikh AB, Girouin N, Colombel M et al (2009) Evaluation of T2-weighted and dynamic contrast-enhanced MRI in localizing prostate cancer before repeat biopsy. Eur Radiol 19:770–778
Comet-Batlle J, Vilanova Busquets J, Barcelo Vidal C et al (2011) Prostate cancer detection with MR spectroscopic imaging in the peripheral and transitional zones in patients with persistently elevated PSA with or without previous negative biopsies. Long term follow-up. Eur Urol 10(Suppl):854
Paticier G, Rigou G, Deminiere C et al (2011) Contrast-enhanced U.S:-guides biopsies following MRI in men with elevated PSA and previous negative biopsy. J Clin Oncol 29:(Suppl):15130
Sciarra A, Barentsz J, Bjartell A et al (2011) Advances in magnetic resonance imaging: how they are changing the management of prostate cancer. Eur Urol 59:962–977
Zangos S, Eichler K, Thalhammer A et al (2010) MR-guided interventions of the prostate gland: a literature review. Rofo 182:947–953
Bonekamp D, Jacobs MA, El-Khouli R et al (2011) Advancements in MR imaging of the prostate: from diagnosis to interventions. Radiographics 31:677–703
Hambrock T, Hoeks C, Hulsbergen-van de Kaa C et al (2012) Prospective assessment of prostate cancer aggressiveness using 3-T diffusion-weighted magnetic resonance imaging-guided biopsies versus a systematic 10-core transrectal ultrasound prostate biopsy cohort. Eur Urol 61:177–184
Hadaschik BA, Kuru TH, Tulea C et al (2011) A novel stereotactic prostate biopsy system integrating pre-interventional magnetic resonance imaging and live ultrasound fusion. J Urol 186:2214–2220
Hoeks CM, Barentsz JO, Hambrock T et al (2011) Prostate cancer: multiparametric MR imaging for detection, localization, and staging. Radiology 261:46–66
Interessenkonflikt
Der korrespondierende Autor gibt für sich und seine Koautoren an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hegele, A., Skrobek, L., Hofmann, R. et al. Multiparametrisches MRT, Elastographie, kontrastmittelverstärkter Ultraschall. Urologe 51, 1270–1277 (2012). https://doi.org/10.1007/s00120-012-2874-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00120-012-2874-x